文献速递脑血管病

急性缺血性卒中合并ST段抬高型心肌梗死患者的患病率与结局(2016-2019年全国住院患者样本结果)

Prevalence and Outcomes of Patients With Acute Ischemic Stroke With Concomitant ST-Segment-Elevation Myocardial Infarction (Results From National Inpatient Sample 2016-2019).
PubMed 文献 · Stroke · 2024-03-26

基于美国全国住院患者样本2016-2019年数据,急性缺血性卒中住院患者中0.3%合并STEMI,该组死亡率为28.3%,无STEMI组为3.7%;合并STEMI与死亡(OR 8.37)及颅内出血(OR 2.23)相关;STEMI亚组中14.3%接受经皮冠状动脉介入治疗,该治疗与死亡和颅内出血无显著关联。

要点

  • 急性缺血性卒中患者中合并STEMI的患病率为0.3%。
  • 合并STEMI与较高的死亡几率相关(OR 8.37,95%CI 7.25-9.66)。
  • STEMI亚组中经皮冠状动脉介入治疗与死亡和颅内出血无显著关联。

核心结论

  • 急性缺血性卒中合并STEMI的患者死亡率较高。
  • 在急性缺血性卒中合并STEMI的患者亚组中,经皮冠状动脉介入治疗与死亡和颅内出血的几率增加无关。

研究设计与样本

  • 研究分析了2016年至2019年全国住院患者样本中的急性缺血性卒中住院患者。
  • 急性缺血性卒中和STEMI通过国际疾病分类第十版诊断代码定义,非STEMI患者被排除。
  • 总样本量为2 080 795例急性缺血性卒中患者,其中0.3%(n=6275)合并STEMI;采用多因素logistic回归分析评估STEMI与主要结局死亡及次要结局的关联,并对接受经皮冠状动脉介入治疗的STEMI患者进行亚组分析。

主要发现

  • 在合并STEMI的急性缺血性卒中患者中,平均年龄70.5岁,女性占50.1%,白人占69.5%。
  • STEMI组死亡1775例(28.3%),无STEMI组死亡76 435例(3.7%)。
  • STEMI组最常见的并发症为急性肾损伤、颅内出血和室性心律失常。
  • 所有次要结局均与STEMI诊断相关(OR 3.19,95%CI 2.82-3.6;P≤0.001)。
  • STEMI与死亡(OR 8.37,95%CI 7.25-9.66;P≤0.001)和颅内出血(OR 2.23,95%CI 1.84-2.70;P≤0.001)相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute myocardial infarction may concomitantly occur with acute ischemic stroke. The prevalence, complications, and outcomes of acute ST-segment-elevation myocardial infarction (STEMI) in patients hospitalized with acute ischemic stroke are not well studied. METHODS: We examined hospitalized patients with acute ischemic stroke who were included in the National Inpatient Sample from 2016 to 2019. Acute ischemic stroke and STEMI were defined by using the International Classification of Diseases-Tenth Revision diagnostic codes. Patients with Non-STEMI were excluded. The prevalence of complications and outcomes were expressed as percentages. Multivariable logistic regression analysis was used to examine the association of STEMI with a primary outcome of mortality and secondary outcomes. A subgroup analysis of patients with STEMI who underwent percutaneous coronary intervention was also performed. RESULTS: Of the total (n=2 080 795) patients with acute ischemic stroke, 0.3% (n=6275; mean age, 70.5 years, 50.1% females, 69.5% White) also had STEMI diagnosed during the hospitalization. Of these, 1775 (28.3%) died in the STEMI group and 76 435 (3.7%) died in the group without STEMI. The most frequent complications in the STEMI group were acute kidney injury, intracranial hemorrhage, and ventricular arrhythmias. All secondary outcomes were associated with the diagnosis of STEMI (odds ratio [OR], 3.19 [95% CI, 2.82-3.6]; P≤0.001). STEMI was associated with mortality (OR, 8.37 [95% CI, 7.25-9.66]; P≤0.001) and intracranial hemorrhage (OR, 2.23 [95% CI, 1.84-2.70]; P≤0.001). Percutaneous coronary intervention was performed in 14.3% of STEMI subgroup patients. Percutaneous coronary intervention is not associated with mortality (OR, 0.93 [95% CI, 0.6-1.43]; P=0.7), and intracranial hemorrhage (OR, 1.54 [95% CI, 0.0.93-2.56]; P=0.1). CONCLUSIONS: Patients with acute ischemic stroke with STEMI have a higher percentage of mortality. Percutaneous coronary intervention in the subgroup of patients with acute ischemic stroke with concomitant STEMI was not associated with increased odds of mortality and intracranial hemorrhage.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Mehta S, Kakouros N, Mir T, et al. Prevalence and Outcomes of Patients With Acute Ischemic Stroke With Concomitant ST-Segment-Elevation Myocardial Infarction (Results From National Inpatient Sample 2016-2019). Stroke. 2024. PMID: 38529635. doi:10.1161/STROKEAHA.123.044550

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。